Nasdaq futures news indicates a boost of 0.3% driven by biotech gains, as FDA approvals for innovative drugs increase sentiment within the wider technology ecosystem. Its share price has gone up quite a bit, and it recently raised $500 million through a private placement. Lee believes the suspension of economic data releases from federal agencies is a "sidebar issue," adding that past shutdowns have had little lasting impact on equities. The widely followed strategist, who called 2025′s bull run to all-time highs in stocks, expects the S&P 500 to reach at least 7,000 by December with potential for further gains. Nasdaq futures news shows traders rotating back into growth stocks on renewed hopes for a softer Fed stance. Futures climbed 0.5%, driven by strong pre-market moves in the cybersecurity segment.